Wei Xu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Replacement Therapy

Epidermal Growth Factor Receptor

Advanced Non Small Cell Lung Cancer

Top Venues

Cell death & disease

Cancer gene therapy

Molecular cancer

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Jiajun Tian, Peng Cui, Haiyan Zhang, Zhenghua Lv, Wei Xu
Endoscopic Suture With Chemocauterization: An Effective Treatment of Congenital Pyriform Sinus Fistula. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023)
Huimin Zhang, Chunhong Qin, Changming An, Xiwang Zheng, Shuxin Wen, Wenjie Chen, Xianfang Liu, Zhenghua Lv, Pingchang Yang, Wei Xu, Wei Gao, Yongyan Wu
Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer. Molecular cancer 20 (1) (2021)
Xianfang Liu, Huiyuan Suo, Shengli Zhou, Zhenxing Hou, Mingqiang Bu, Xiuxiu Liu, Wei Xu
Afatinib induces pro-survival autophagy and increases sensitivity to apoptosis in stem-like HNSCC cells. Cell death & disease 12 (8) (2021)
Hong Liu, Zhancheng Zhang, Shenli Zhou, Xianfang Liu, Guodong Li, Bing Song, Wei Xu
Claudin-1/4 as directly target gene of HIF-1α can feedback regulating HIF-1α by PI3K-AKT-mTOR and impact the proliferation of esophageal squamous cell though Rho GTPase and p-JNK pathway. Cancer gene therapy (2021)
Wei Gao, Yuliang Zhang, Hongjie Luo, Min Niu, Xiwang Zheng, Wanglai Hu, Jiajia Cui, Xuting Xue, Yunfeng Bo, Fengsheng Dai, Yan Lu, Dongli Yang, Yujia Guo, Huina Guo, Huizheng Li, Yu Zhang, Tao Yang, Li Li, Linshi Zhang, Rui Hou, Shuxin Wen, Changming An, Teng Ma, Lei Jin, Wei Xu, Yongyan Wu
Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis. Cell death & disease 11 (10) (2020)